Currently, Wang Guanxi's No. 1 Fund has a debt of US$5.5 billion, and No. 2 Fund has a debt of US$1.2 billion, with a total debt of US$6.7 billion.

However, the acquisition of Cardinah Health Group has allowed Wang Guanxi's consortium to extend its tentacles to the US pharmaceutical industry.

The American Cardinah Health Group is actually a top 100 companies in the world, a multinational group specializing in the scientific research of health nutrition products, health foods, production and global sales of medical and health care.

Founded in 1971, Cardinal International Group is now a supplier of 90% of hospitals in the United States.

Now the world's top academicians in health and nutritional foods, biology and world-renowned international biologists have carried out extensive technical cooperation to develop a new generation of health nutrition products that are well-known and internationally leading. It also uses the world's most advanced biological gene purification technology to maximize the activity of extracted nutrients.

The group's series of products have established sales outlets in more than 100 countries and regions around the world, mainly including the United States, EU countries, Canada, Japanese benzene, Singapore, etc.

The entire group has a very experienced working team.

Now there are 1,800 pharmacies, 550 medical staff and consultants.

The company's medical consultants use the company's strong financial foundation to engage in more than 1,600 research in more than 200 medical fields. The company has cooperated with 2,900 hospitals, other medical institutions, retail pharmacies, and pharmaceutical manufacturers. With Dublin and Ohio as the center, it has opened branches on all five continents.

Moreover, the group's products have won the highest international quality assessment supervisor, the world's largest nutritional and health products manufacturer and seller; the world's sales champion, with a turnover of US$56.9 billion in 2004; the global nutritional and health products market share reached 40%; the highest international credit rating was given to aaaaa1; it has the world's largest nutritional product research and development center and more than 1,000 scientists specializing in product research and development, of which more than half have doctoral degrees.

Now it belongs to Wang Guanxi.

Luo Baowen used the financial statements.

“Boss, this is the balance sheet of Cardinah Health Group”

"Well, I'll take a good look." Wang Guanxi took a closer look.

Total current assets                                                             �

Total non-current assets                                                            �

Total assets total US$23.448 billion

Total current liabilities                                                             

Total non-current liabilities                                                            

Total liabilities totaled US$15.701 billion

Total net assets      7.747 billion US dollars.

The current net worth is US$7.747 billion, while the market value is US$6.09 billion!

Of course, although the market value is only US$6.09 billion, Cardinah Health Group is a Fortune 500 company with sales catching up with Ford Motor Company.

The turnover in 2008 was US$87.408 billion in operating income

Operating cost $83.631 billion

Operating gross profit                                                             �

Operating expenditure totaled US$2.521 billion

Net profit                                                              �

The dividends to shareholders are quite large, and they basically pay dividends every year.

Although the profits are low, they occupy a very large market and are basically in a monopoly position in the industry and have a huge interest chain.

Although it is a monopoly enterprise, the price is not high. Because the price is not high, other new enterprises dare not enter this industry rashly because there is no profit.

For example, Coca-Cola, a bottle of Coca-Cola barely raises the price, keeping the price to a minimum, preventing companies from entering this market. Because the price is low and the profit is low, no company dares to enter this market again. Even if it enters the market, it will not be able to beat Coca-Cola and will soon suffer a terrible loss.

This is also the case with Cardinah Health Group operating in this way, with prices being low and other companies dare not come in to compete.

Luo Baowen said: "Boss, the operating costs of Cardinah Health Group are very high. Should we move some production lines to China, where labor costs are low?"

Wang Guanxi said, "Leave it to the staff of the Cardina family."

In the future, due to drug problems, Cardinah Group paid $5.6 billion in opioid lawsuits. If there was a problem with the drug, it would be a very terrible thing.

This requires employees who produce medicines and supervisory management, who have extremely high qualities and ethics, but such employees are very costly.

After thinking about it, Wang Guanxi said: "This Cardinal Group occupies nearly 90% of the hospital medicine and nutritional food market in the United States. It has a good reputation and cannot just reduce costs and pursue profits. In this way, it will only create unfavorable reputations around the world."

"Don't apply for the drug production lines of Cardinah Group. Some non-core companies are required to not move out strictly production lines."

"Yes, boss" Luo Baowen asked again: "The CEO, are we going to replace it?"

Currently, the chairman of Cardinah Health Group is still Evan Cardinah, and the CEO is also the Cardinah family who accepts his fate.

Wang Guanxi will arrange for the Chief Financial Officer and executive director to join Cardinah Health Group. The CEO should be replaced.

Thinking of this, Wang Guanxi said: "Let me take a look at the information on Cardinah Health Group's executives."

"Yes, boss" Luo Baowen quickly brought information on executives of Cardinah Health Group.

Chief Information Officer

CFO

Chief Legal and Compliance Officer

Executive Vice President, Strategy and Enterprise Development-

Chief Human Resources Officer

CEO of the Medical Department

CEO of Pharmaceuticals

CEO.

Wang Guanxi looked at all these positions, and eventually he decided to promote Michael Kaufman, CEO of the pharmaceutical division, to serve as CEO of Cardinah Health.

The original CEO who belonged to the Cardinas family was fired.

Of course, other executives who have accepted the fate of the Cardinal family are still there, but the position of CEO requires the talent chosen by Wang Guanxi.

Soon Michael Kaufman came to Wang Guanxi.

"Boss!" Michael Kaufman once served as president of North America at PepsiCo and Pepsi Beverage Company.

He also serves as executive vice president of Pepsi Bottled Group.

He is also a member of the board of directors of the National Urban Alliance and a member of the board of directors of Boston College, but the salary is not as high as that of Cardinah Health.

Wang Guanxi said: "Michael Kaufman, from now on, you will be the CEO of Cardinah Health Group and serve as the executive director."

"Yes, boss!" Michael Kaufman was extremely excited. He thought that the position of the CEO would fall on other executives, but he didn't expect that it would fall on himself, like a pie falling from the sky.

The CEO of Cardinah Health Group pays several times more than the CEO of the pharmaceutical division.

After chatting, Michael Kaufman suddenly said, "Boss, I plan to move part of the production line of Cardinah Health Group to the coastal areas of China. Where is the labor cost and the basic raw material cost is also low. This will help Cardinah Health Group reduce costs and firmly occupy the market share of American hospital drugs."

Wang Guanxi: "Go and do it, especially those production of masks and other products, all of them will be moved out of the United States."

"Yes, boss" Michael Kaufman was very excited and then talked about his own strategic plan.

Wang Guanxi nodded, quite satisfied with Michael Kaufman.

The matter of Cardinah Health has been settled, and the next step is to close the short orders on the Dow Jones Index.

After closing the position, another big buyer!

But I will wait for the Cardinah hedge fund to break the position first!

At this time, Wang Guanxi saw a news that was bad for the stock market.
Chapter completed!